<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="126121">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01986374</url>
  </required_header>
  <id_info>
    <org_study_id>HCG 2013</org_study_id>
    <nct_id>NCT01986374</nct_id>
  </id_info>
  <brief_title>Injection of Hormone to Enhance Implantation in Embryo Transfer After IVF</brief_title>
  <official_title>Intrauterine Injection of Human Chorionic Gonadotropin to Enhance Embryo Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Servy Massey Fertility Insititute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Servy Massey Fertility Insititute</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The endometrium is deprived of signals form the embryo in IVF conditions. Studies suggest
      that placing HCG into the uterus prior to embryo transfer can enhance implantation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is in pilot phase, uncontrolled. The risks appear to be minimal and there are
      conflicting  new reports being announced.

      A small amount of fluid with HCG is injected into the uterus. HCG is a potent signal to the
      uterus for preparation for implantation.

      This is not a funded study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>HCG enhances pregnancy rate</measure>
    <time_frame>9 months.</time_frame>
    <safety_issue>No</safety_issue>
    <description>compare pregnancy rates to established clinical norms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>implantation rate</measure>
    <time_frame>9 months.</time_frame>
    <safety_issue>No</safety_issue>
    <description>compare implantation rate per embryo to clinical norms.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>HCG is introduced with small catheter.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>phase 1 non randomized pilot</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HCG is introduced</intervention_name>
    <description>must have good blastocysts</description>
    <arm_group_label>HCG is introduced with small catheter.</arm_group_label>
    <other_name>Improve results of IVF and embryo transfer</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - infertility patients undergoing IVF with good expectation of two embryos developing by
        day 5. must speak and read English.

        Exclusion Criteria:abnormal uterus

        -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>47 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joe B Massey, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Servy Massey Fertilty Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joe B Massey, MD</last_name>
    <phone>4042287199</phone>
    <email>drmassey@ivfga.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dawn Cooke, MA</last_name>
    <phone>4042287199</phone>
    <email>dawnc@ivfga.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Servy Massey Fertility Insititute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30327</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dawn Cook, MA</last_name>
      <phone>404-228-7199</phone>
      <email>dawnc@ivfga.com</email>
    </contact>
    <investigator>
      <last_name>Joe B Massey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Mansour R, Tawab N, Kamal O, El-Faissal Y, Serour A, Aboulghar M, Serour G. Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection: a prospective randomized study. Fertil Steril. 2011 Dec;96(6):1370-1374.e1. doi: 10.1016/j.fertnstert.2011.09.044. Epub 2011 Nov 1.</citation>
    <PMID>22047664</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 15, 2013</lastchanged_date>
  <firstreceived_date>November 11, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IVF , embryo implantation, HCG</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Chorionic Gonadotropin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
